Cargando…

Gelatinase B/matrix metalloproteinase-9 is a phase-specific effector molecule, independent from Fas, in experimental autoimmune encephalomyelitis

Gelatinase B/matrix metalloproteinase-9 (MMP-9) triggers multiple sclerosis (MS) and the animal model of experimental autoimmune encephalomyelitis (EAE) by the breakdown of the blood-brain barrier. Interestingly, MMP-9 is beneficial in systemic autoimmunity caused by Fas-deficiency. Fas-deficient (f...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ugarte-Berzal, Estefania, Berghmans, Nele, Boon, Lise, Martens, Erik, Vandooren, Jennifer, Cauwe, Bénédicte, Thijs, Greet, Proost, Paul, Van Damme, Jo, Opdenakker, Ghislain
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6166937/ https://www.ncbi.nlm.nih.gov/pubmed/30273366 http://dx.doi.org/10.1371/journal.pone.0197944

Ejemplares similares

MMP-9/Gelatinase B Degrades Immune Complexes in Systemic Lupus Erythematosus
por: Ugarte-Berzal, Estefania, et al.
Publicado: (2019)

Proteoform Analysis of Matrix Metalloproteinase-9/Gelatinase B and Discovery of Its Citrullination in Rheumatoid Arthritis Synovial Fluids
por: Grillet, Bernard, et al.
Publicado: (2021)

Gelatinase B/Matrix Metalloproteinase-9 as Innate Immune Effector Molecule in Achalasia
por: Furuzawa-Carballeda, Janette, et al.
Publicado: (2018)

Endotoxemia shifts neutrophils with TIMP-free gelatinase B/MMP-9 from bone marrow to the periphery and induces systematic upregulation of TIMP-1
por: Vandooren, Jennifer, et al.
Publicado: (2017)

EDTA/gelatin zymography method to identify C1s versus activated MMP‐9 in plasma and immune complexes of patients with systemic lupus erythematosus
por: Ugarte‐Berzal, Estefania, et al.
Publicado: (2018)

Glycosylation of matrix metalloproteases and tissue inhibitors: present state, challenges and opportunities
por: Boon, Lise, et al.
Publicado: (2016)

Neutrophils and Activated Macrophages Control Mucosal Immunity by Proteolytic Cleavage of Antileukoproteinase
por: Vandooren, Jennifer, et al.
Publicado: (2018)

Internal Disulfide Bonding and Glycosylation of Interleukin-7 Protect Against Proteolytic Inactivation by Neutrophil Metalloproteinases and Serine Proteases
por: Vandooren, Jennifer, et al.
Publicado: (2021)

Thymocyte development in the absence of matrix metalloproteinase-9/gelatinase B
por: Gounko, Natalia V., et al.
Publicado: (2016)

Matrix Metalloproteinase-9-Generated COOH-, but Not NH(2)-Terminal Fragments of Serum Amyloid A1 Retain Potentiating Activity in Neutrophil Migration to CXCL8, With Loss of Direct Chemotactic and Cytokine-Inducing Capacity
por: Gouwy, Mieke, et al.
Publicado: (2018)

Propeptide glycosylation and galectin‐3 binding decrease proteolytic activation of human proMMP‐9/progelatinase B
por: Boon, Lise, et al.
Publicado: (2018)

Physiological fibrin hydrogel modulates immune cells and molecules and accelerates mouse skin wound healing
por: Pereira, Rafaela Vaz Sousa, et al.
Publicado: (2023)

Chlorite-Oxidized Oxyamylose (COAM) Has Antibacterial Activity and Positively Affects Skin Wound Healing
por: Pereira, Rafaela Vaz Sousa, et al.
Publicado: (2022)

Heterogeneity of serum gelatinases MMP-2 and MMP-9 isoforms and charge variants
por: Rossano, Rocco, et al.
Publicado: (2014)

Insufficiently Defined Genetic Background Confounds Phenotypes in Transgenic Studies As Exemplified by Malaria Infection in Tlr9 Knockout Mice
por: Geurts, Nathalie, et al.
Publicado: (2011)

Angiostatic, tumor inflammatory and anti-tumor effects of CXCL4(47–70) and CXCL4L1(47–70) in an EGF-dependent breast cancer model
por: Van Raemdonck, Katrien, et al.
Publicado: (2014)

Rescue from acute neuroinflammation by pharmacological chemokine-mediated deviation of leukocytes
por: Berghmans, Nele, et al.
Publicado: (2012)

Bivalent Inhibitor with Selectivity for Trimeric MMP-9 Amplifies Neutrophil Chemotaxis and Enables Functional Studies on MMP-9 Proteoforms
por: Nuti, Elisa, et al.
Publicado: (2020)

Inhibition of gelatinase B/MMP-9 does not attenuate colitis in murine models of inflammatory bowel disease
por: de Bruyn, Magali, et al.
Publicado: (2017)

Comparisons of gut microbiota profiles in wild-type and gelatinase B/matrix metalloproteinase-9-deficient mice in acute DSS-induced colitis
por: de Bruyn, Magali, et al.
Publicado: (2018)

Differential inhibition of activity, activation and gene expression of MMP-9 in THP-1 cells by azithromycin and minocycline versus bortezomib: A comparative study
por: Vandooren, Jennifer, et al.
Publicado: (2017)

Inhibition of renal fibrosis with a human CXCL9‐derived glycosaminoglycan‐binding peptide
por: Poosti, Fariba, et al.
Publicado: (2022)

Suramin increases cartilage proteoglycan accumulation in vitro and protects against joint damage triggered by papain injection in mouse knees in vivo
por: Guns, Laura-An, et al.
Publicado: (2017)

The Biological Potential Hidden in Inclusion Bodies
por: Gifre-Renom, Laia, et al.
Publicado: (2020)

Soluble cytokine receptor levels in aqueous humour of patients with specific autoimmune uveitic entities: sCD30 is a biomarker of granulomatous uveitis
por: Abu El-Asrar, Ahmed M., et al.
Publicado: (2019)

Recombinant Protein-Based Nanoparticles: Elucidating Their Inflammatory Effects In Vivo and Their Potential as a New Therapeutic Format
por: Gifre-Renom, Laia, et al.
Publicado: (2020)

From ELISA to Immunosorbent Tandem Mass Spectrometry Proteoform Analysis: The Example of CXCL8/Interleukin-8
por: Metzemaekers, Mieke, et al.
Publicado: (2021)

Matrix Metalloproteinase-9 Is Involved in Chronic Lymphocytic Leukemia Cell Response to Fludarabine and Arsenic Trioxide
por: Amigo-Jiménez, Irene, et al.
Publicado: (2014)

Genetic variations and plasma levels of gelatinase A (matrix metalloproteinase-2) and gelatinase B (matrix metalloproteinase-9) in proliferative diabetic retinopathy
por: Beránek, Michal, et al.
Publicado: (2008)

Interferons and other cytokines, genetics and beyond in COVID-19 and autoimmunity
por: Opdenakker, Ghislain, et al.
Publicado: (2021)

Biological Activity of CXCL8 Forms Generated by Alternative Cleavage of the Signal Peptide or by Aminopeptidase-Mediated Truncation
por: Mortier, Anneleen, et al.
Publicado: (2011)

Inhibition of Neutrophil Collagenase/MMP-8 and Gelatinase B/MMP-9 and Protection against Endotoxin Shock
por: Qiu, Zheng, et al.
Publicado: (2014)

Metalloproteinase-mediated release of human Fas ligand
Publicado: (1995)

Recent Findings on the Role of Gelatinases (Matrix Metalloproteinase-2 and -9) in Osteoarthritis
por: Galasso, Olimpio, et al.
Publicado: (2012)

Interphotoreceptor retinoid-binding protein as biomarker in systemic autoimmunity with eye inflictions
por: Descamps, F J, et al.
Publicado: (2008)

Dystroglycan is selectively cleaved at the parenchymal basement membrane at sites of leukocyte extravasation in experimental autoimmune encephalomyelitis
por: Agrawal, Smriti, et al.
Publicado: (2006)

Dual Role for Fas Ligand in the Initiation of and Recovery from Experimental Allergic Encephalomyelitis
por: Sabelko-Downes, Kimberly A., et al.
Publicado: (1999)

Matrix metalloproteinase-1, soluble Fas ligand, and soluble Fas antigen levels in patients with multiple organ dysfunction syndrome
por: Endo, S, et al.
Publicado: (1998)

Matrix metalloproteinases and soluble Fas/FasL system as novel regulators of apoptosis in children and young adults on chronic dialysis
por: Musiał, Kinga, et al.
Publicado: (2011)

Natural Haemozoin Induces Expression and Release of Human Monocyte Tissue Inhibitor of Metalloproteinase-1
por: Polimeni, Manuela, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_rkr9ar5f6hnq01hh7gsgkb61tg